Approval · Notice of Compliance 2554 · 2001
PARIET: Notice of Compliance 2554
Issued May 7, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2554
- Date
- May 7, 2001
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
Medicinal ingredients
- RABEPRAZOLE SODIUM 10 MG per TAB
- RABEPRAZOLE SODIUM 20 MG per TAB